Fc-mediated antibody effector functions during respiratory syncytial virus infection and disease

EA Van Erp, W Luytjes, G Ferwerda… - Frontiers in …, 2019 - frontiersin.org
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections
and hospitalization in infants under 1 year of age and there is currently no market-approved …

Sex differences in vaccine-induced humoral immunity

S Fischinger, CM Boudreau, AL Butler… - Seminars in …, 2019 - Springer
Vaccines are among the most impactful public health interventions, preventing millions of
new infections and deaths annually worldwide. However, emerging data suggest that …

Antibody responses to envelope glycoproteins in HIV-1 infection

DR Burton, JR Mascola - Nature immunology, 2015 - nature.com
Antibody responses to the HIV-1 envelope glycoproteins can be classified into three groups.
Binding but non-neutralizing responses are directed to epitopes that are expressed on …

Engaging innate immunity in HIV-1 cure strategies

NL Board, M Moskovljevic, F Wu, RF Siliciano… - Nature Reviews …, 2022 - nature.com
Combination antiretroviral therapy (ART) can block multiple stages of the HIV-1 life cycle to
prevent progression to AIDS in people living with HIV-1. However, owing to the persistence …

Polyfunctional HIV-specific antibody responses are associated with spontaneous HIV control

ME Ackerman, A Mikhailova, EP Brown… - PLoS …, 2016 - journals.plos.org
Elite controllers (ECs) represent a unique model of a functional cure for HIV-1 infection as
these individuals develop HIV-specific immunity able to persistently suppress viremia …

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity

ME Ackerman, M Crispin, X Yu… - The Journal of …, 2013 - Am Soc Clin Investig
While the induction of a neutralizing antibody response against HIV remains a daunting
goal, data from both natural infection and vaccine-induced immune responses suggest that it …

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family

M Bonsignori, J Pollara, MA Moody, MD Alpert… - Journal of …, 2012 - Am Soc Microbiol
ABSTRACT The ALVAC-HIV/AIDSVAX-B/E RV144 vaccine trial showed an estimated
efficacy of 31%. RV144 secondary immune correlate analysis demonstrated that the …

[KNJIGA][B] HIV and the pathogenesis of AIDS.

JA Levy - 1994 - cabidigitallibrary.org
This book grew out of a scientific review, originally published in Microbiological Reviews. It
has been updated and expanded-now citing more than 2100 references (100 pages of the …

Mouse model recapitulating human Fcγ receptor structural and functional diversity

P Smith, DJ DiLillo, S Bournazos… - Proceedings of the …, 2012 - National Acad Sciences
The in vivo biological activities of IgG antibodies result from their bifunctional nature, in
which antigen recognition by the Fab is coupled to the effector and immunomodulatory …

Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity

M Veillette, A Désormeaux, H Medjahed… - Journal of …, 2014 - Am Soc Microbiol
ABSTRACT Anti-HIV-1 envelope glycoprotein (Env) antibodies without broadly neutralizing
activity correlated with protection in the RV144 clinical trial, stimulating interest in other …